Ceeta Industries Ltd. (BOM:514171)
47.48
+0.13 (0.27%)
At close: Jul 30, 2025
Ligand Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Ceeta Industries had annual revenue of 220.26M INR with 87.58% growth. Ceeta Industries had revenue of 50.24M in the quarter ending March 31, 2025, with 97.54% growth.
Revenue
220.26M
Revenue Growth
+87.58%
P/S Ratio
3.11
Revenue / Employee
3.73M
Employees
59
Market Cap
685.09M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 220.26M | 102.83M | 87.58% |
Mar 31, 2024 | 117.42M | 77.24M | 192.22% |
Mar 31, 2023 | 40.18M | 31.87M | 383.54% |
Mar 31, 2022 | 8.31M | -6.40M | -43.49% |
Mar 31, 2021 | 14.71M | -24.58M | -62.57% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,729.85B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,429.39B |
Infosys | 1,672.76B |
Hindustan Unilever | 639.28B |